Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
GH
GH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GH News
Following Grail's Study Setback, What Remains for Cancer Blood Screening?
Feb 26 2026
Barron's
U.S. Stocks Rise Following Landmark Supreme Court Ruling
Feb 20 2026
NASDAQ.COM
Guardant Health Acquires MetaSight Diagnostics for $59M
Feb 20 2026
seekingalpha
GUARDANT HEALTH INC: STIFEL INCREASES TARGET PRICE FROM $120 TO $130
Feb 20 2026
moomoo
Stock Market Movers: Opendoor, Nvidia, Grail, Newmont, AppLovin, and Others
Feb 20 2026
Barron's
Guardant Health Reports Strong Q4 2025 Earnings with Significant Growth
Feb 20 2026
seekingalpha
Latest Ratings and Outlook from Wall Street
Feb 17 2026
CNBC
Guardant Health Launches Colorectal Cancer Screening Grant Program
Feb 12 2026
PRnewswire
Guardant Health Launches Colorectal Cancer Screening Grant Program
Feb 12 2026
Newsfilter
AI Drives Transformation in Genomics and Biological Manufacturing
Feb 10 2026
Newsfilter
GUARDANT HEALTH INC: UBS Increases Price Target from $110 to $175
Jan 30 2026
moomoo
Guardant Health's Optimistic Future Outlook
Jan 30 2026
NASDAQ.COM
Guardant Health Stock Soars Amid New Collaborations
Jan 30 2026
Fool
Guardant Health's Guardant360 CDx Approved by FDA as Companion Diagnostic for mCRC Treatment
Jan 22 2026
Benzinga
Guardant Health (GH) Receives FDA Approval for Guardant360 CDx Diagnostic to Enhance Colorectal Cancer Treatment
Jan 22 2026
seekingalpha
IWO ETF Hits 52-Week High of $351.77, Last Trade at $346.95
Jan 20 2026
NASDAQ.COM
Show More News
